News and Events Appointment of Dr Malcolm Barratt-Johnson to the Board of NovaBiotics Nov 10, 2020 The truth about why we need this COVID-19 treatment right now! Oct 22, 2020 NovaBiotics secures £1m funding for COVID 19 project Oct 16, 2020 OBE for NovaBiotics’ CEO in the Queen’s Birthday Honours List Oct 12, 2020 “Antimicrobial Susceptibility Testing of Antimicrobial Peptides to Better Predict Efficacy” published today Jul 7, 2020 NovaBiotics announces fast-track repurposing of its experimental drug Nylexa for COVID-19 trials and plans for earliest possible compassionate use Apr 13, 2020 NovaBiotics publishes further clinical data on the safety and efficacy of Novexatin® Mar 31, 2020 Next Entries » Categories Press Releases Events In the news Archives 2021 2020
“Antimicrobial Susceptibility Testing of Antimicrobial Peptides to Better Predict Efficacy” published today Jul 7, 2020
NovaBiotics announces fast-track repurposing of its experimental drug Nylexa for COVID-19 trials and plans for earliest possible compassionate use Apr 13, 2020
